Neoadjuvant Cetuximab β Plus Tislelizumab and Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma: A Prospective, Single-Arm, Phase II Clinical Study (ESMO Asia 2026) - Oct 1, 2026 - Abstract #566P; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Clinical • Metastases • P2 data • Nasopharyngeal Carcinoma • Oncology • Solid Tumor
|
|
Guoyi Zhang; Xiaofan Mao; Yichu Nie; Haijun Wu; Fang Liu; Haojiang Li; Rong Yan; Jing Zhang; Yinuan Zhang; Maoyuan Li; Jianchun Su; Yuchun Niu
|